Send me a link:

*Text messaging rates may apply.

 Dow Down 0.17% Nasdaq Down 0.40%

Intercept Pharmaceuticals, Inc. (ICPT)

-NasdaqGS
218.48 Down 2.52(1.14%) 11:57AM EDT - Nasdaq Real Time Price
Prev Close:221.00
Open:220.02
Bid:218.96 x 100
Ask:219.85 x 100
1y Target Est:454.45
Beta:-3.02
Earnings Date:Aug 11 - Aug 15 (Est.)
Day's Range:217.20 - 221.92
52wk Range:42.41 - 497.00
Volume:69,279
Avg Vol (3m):470,986
Market Cap:4.61B
P/E (ttm):N/A
EPS (ttm):-16.80
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
ICPTDown 1.14%4.61B
AZNDown 0.74%93.23B
SLXPDown 1.71%8.24B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):2,873.80
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-14.82
Quarterly EPS Est (Jun-14) :-0.12
Mean Recommendation*:1.9
PEG Ratio (5 yr expected):3.77

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Intercept Pharmaceuticals, Inc., a development stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics to treat chronic liver and intestinal diseases utilizing its proprietary bile acid chemistry. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback